# Onabotulinum Toxin A (Botox) in the Treatment of Transfer Dysphagia

> **NCT04695600** · PHASE2,PHASE3 · UNKNOWN · sponsor: **All India Institute of Medical Sciences** · enrollment: 100 (estimated)

## Conditions studied

- Transfer Dysphagia
- Oropharyngeal Dysphagia
- Cricopharyngeus Muscle Dysfunction
- Dysphagia, Late Effect of Stroke

## Interventions

- **DRUG:** Botulinum Toxin Type A Injection [Botox]

## Key facts

- **NCT ID:** NCT04695600
- **Lead sponsor:** All India Institute of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-08-22
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04695600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04695600, "Onabotulinum Toxin A (Botox) in the Treatment of Transfer Dysphagia". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT04695600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*